Categories: Artificial IntelligenceBioTechEngineeringHealthTechMedtechPersonalPlatformTechnology
Introducing Nerai, a Swiss biotech company engineering precise, next-gen genome editors to cure inherited diseases through innovative CRISPR technology.
Investors 1
Mentions in press and media 6
| Date | Title | Description |
| 24.06.2025 | The >>venture>> Grand Prize goes to MYNERVA |
From AI-driven surgeries to upcycled food systems and decentralized energy finance, this year’s >>venture>> winners reflect a deep alignment with global sustainability and digital transformation. Their innovations reveal a unif... |
| 22.05.2025 | 18 startups selected for >>venture>> final pitches |
The >>venture>> competition is one of the oldest and most prestigious competitions for start-ups in Switzerland. Companies compete in six verticals for the category winner award and the Grand Prize worth CHF 150,000. The winner... |
| 26.03.2025 | Venture Leaders Biotech 2025 cohort revealed |
After reviewing over 70 applications, the jury of investors and biotech experts selected the ten startups to participate in the Boston roadshow, one of the world’s leading life science hubs. The Venture Leaders program will allow the selec... |
| 11.11.2024 | Nerai Bio obtains funding to release the full potential of genome editing |
One in ten people worldwide is affected by genetic diseases, and over 90% of them lack approved therapies. Genome editing has revolutionized the way we think and treat these disorders. However, most current technologies like CRISPR (Cluste... |
| 05.07.2024 | InnoBooster injects CHF 750,000 in five projects |
The InnoBooster program an initiative of the Gebert Rüf Stiftung supports university-based, high-potential business cases from the Venture Kick program with the aim of substantially accelerating their market entry. The program provides up ... |
| - | Nerai Bio | “nerai bio” |
Reviews 0
